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Introduction {#sec1}
============

The CNS is a target of HIV-1 infection and serves as a viral reservoir that may not be readily accessed by antiretroviral drugs ([@bib28], [@bib50]). Approaches to HIV-1 eradication will therefore need to take this into account. Moreover, HIV-1 infection drives progressive cognitive impairment, incompletely prevented by antiretroviral therapy (ART), indicating ongoing pathological processes in the brain ([@bib50], [@bib53]). Perivascular macrophages and microglia are productively infected in the CNS and are considered to contribute to local inflammation and neuronal tissue degeneration ([@bib4], [@bib46], [@bib59]).

Astrocytes are the most abundant brain cells and are the predominant neuro-glial cells involved in brain plasticity and neuro-protection ([@bib14]). Multiple studies, both in vitro and ex vivo, have implicated HIV-1 infection of astrocytes, although the nature of the infection is obscure. Ex vivo analyses of post-mortem brain tissue from HIV-1-infected individuals revealed viral proteins, viral nucleic acid, and virions associated with astrocytes ([@bib16], [@bib54], [@bib55]), and laser-capture experiments detected integrated viral DNA in nuclei isolated from astrocytes ([@bib15]). In vitro, rare primary astrocytes are reported as HIV-1 infected ([@bib11], [@bib14], [@bib42]), although this infection appears not to be permissive, because evidence is lacking for de novo infectious viral production ([@bib11], [@bib14], [@bib21], [@bib24], [@bib25], [@bib29], [@bib42], [@bib48], [@bib57]). Lack of productive infection is consistent with failure to detect expression of the HIV-1 receptor CD4 on primary astrocytes and immortalized lines ([@bib3], [@bib38], [@bib44], [@bib48], [@bib58]) and lack of consensus regarding CCR5 or CXCR4 expression ([@bib47], [@bib48], [@bib58]). Transfection of HIV-1 proviral DNA ([@bib19], [@bib20], [@bib51]) or vesicular stomatitis virus G protein (VSV-G)-pseudotyped HIV-1 transduction ([@bib6], [@bib10], [@bib26]) into astrocytes revealed that bypassing the entry step allows HIV-1 to complete its life cycle and produce new viral RNA, proteins, and infectious particles, demonstrating the absence of major intracellular blocks to HIV-1 replication. Altogether, these data reveal a puzzling inconsistency: if HIV-1 can enter astrocytes using unconventional CD4-independent entry pathways and post-entry HIV-1 is replication competent, why does permissive viral replication not proceed in these cells?

Alternative explanations of astrocyte infection by HIV-1 have been proposed. First, it has been suggested that cell-to-cell transfer of HIV-1 from infected T cells to astrocytes may overcome entry barriers to cell-free infection, allowing astrocyte infection ([@bib22], [@bib37], [@bib43]), potentially via a CD4-independent but CXCR4-dependent mechanism ([@bib33]). Second, cell-free virus capture and endocytosis by astrocytes have been observed ([@bib11], [@bib12], [@bib17], [@bib18], [@bib27], [@bib29], [@bib34]), establishing, at least in vitro, a transient reservoir of infectious virus within a CD81^+^ intracellular compartment ([@bib27]) that can be released and transferred in trans to permissive cells. Although this model may explain detection of viral proteins, nucleic acids, and infectious virus in astrocytes, it does not explain apparently integrated viral genomes associated with astrocytes in ex vivo brain tissue from infected individuals or in vitro cocultures with infected permissive cell types.

An alternative explanation for detection of viral proteins, nucleic acids, and integration products associated with astrocytes may result from their phagocytic capacity. Astrocytes engulf damaged and dying cells or their fragments as a mechanism to avoid local necrosis and subsequent CNS inflammation ([@bib9], [@bib35], [@bib36], [@bib39], [@bib52]). Engulfed cells may be maintained for long periods with minimal degradation ([@bib36]), potentially explaining the observation of astrocytes with a multinuclear morphology ([@bib35]). We have demonstrated that macrophages avidly engulf HIV-1-infected and dying T cells, leading to macrophage infection in the case of macrophage-tropic viruses ([@bib2]). However, when T cells infected with non-macrophage-tropic HIV-1 were engulfed by macrophages, they became positive for viral antigens but were not productively infected ([@bib2], [@bib49]). We therefore hypothesized that astrocytes might, because of recognition of stressed, damaged, and dying cells, engulf HIV-1-infected cells and/or cell debris, thereby becoming positive for viral antigens and nucleic acids without becoming infected.

Here we test this hypothesis using advanced reporter and imaging techniques to probe primary human fetal astrocyte (HFA) cultures exposed to cell-free HIV-1 or infected primary macrophages, the most biologically relevant HIV-1 target cell in the brain. Despite observing uptake and release of HIV-1 particles with the potential to propagate limited infection in trans as observed by others ([@bib11], [@bib12], [@bib17], [@bib27]), we found no evidence for virus-mediated fusion with, or productive infection of, astrocytes after either cell-free or cell-to-cell spread. Coculture of astrocytes with infected macrophages led to tight contact between these cell types, with evidence of astrocyte internalization of virions and infected macrophages and macrophage-derived cellular material but no evidence of astrocyte infection. We therefore suggest astrocyte uptake of virus and material derived from infected cells as an explanation for the apparent infection of astrocytes reported by others, and we conclude that astrocytes are unlikely to function as long-term autonomous viral reservoirs within the CNS.

Results {#sec2}
=======

Astrocytes Are Not Productively Infected by Cell-free HIV-1 {#sec2.1}
-----------------------------------------------------------

Although previous studies have suggested that cell-free HIV-1 may enter and infect astrocytes via unconventional and largely undefined entry pathways, most studies used wild-type HIV-1 with infection readout as release of cell-free viral p24 or infectious virions. Because this approach cannot differentiate between true infection and virion uptake followed by subsequent release, we used replication-competent luciferase reporter (LucR) viruses to probe HFA infectivity. LucR viruses give a sensitive readout of viral infection by reporting on viral entry, reverse transcription, and luciferase translation ([@bib23]). We used primary HFAs as in multiple other HIV-1 infection studies, and we compared their permissivity to infection with monocyte-derived macrophages (MDMs) and highly permissive TZM-bl reporter cells ([@bib41]). The CCR5-tropic (R5) viruses HIV-1BaL-LucR and HIV-1YU2-LucR and the CXCR4-using (X4) virus HIV-1NL4.3LucR were produced by transient 293T transfection and titrated on TZM-bl cells to obtain infectious titer and MOI. Viruses were added at an MOI of 0.1 (based on the TZM-bl cell infection) to similar numbers of TZM-bl cells, MDMs, or HFAs for 24 hr and washed, and the cells cultured for up to 10 days. At the time points shown, cells were lysed and assayed for luciferase signal and culture supernatant was analyzed for p24 content ([Figure 1](#fig1){ref-type="fig"}). Azidothymidine (AZT)-sensitive infection of TZM-bl cells by all viruses peaked at day 2 and waned with time as a result of HIV-1-induced syncytium formation and cell death, which was paralleled by a rapid and prolonged supernatant p24 signal. R5 virus infection kinetics were slower in MDMs than in TZM-bl cells but yielded increasing AZT-sensitive luciferase expression over time, with similar p24 release dynamics. Consistent with its non-macrophage tropism, HIV-1NL4.3-LucR virus failed to productively infect MDMs. By contrast with TZM-bl cells and MDMs, HFAs failed to produce luciferase activity significantly above background with any virus and at any time point ([Figures 1](#fig1){ref-type="fig"}E and 1G). Low-level supernatant p24, ∼10- to 20-fold less than that measured in TZM-bl cells and MDMs, was detected in HFA supernatants with or without AZT treatment over 10 days ([Figure 1](#fig1){ref-type="fig"}H). Using sensitive luciferase reporter viruses, these results confirm previous findings that astrocytes pulsed with cell-free HIV-1 are not productively infected but rather adsorb and release viral p24 over an extended period. Previous studies have failed to detect CD4 and CCR5 on human astrocytes ([@bib48], [@bib58]), whereas CXCR4 expression has been implicated in astrocyte infection ([@bib33]). We investigated this by surface labeling with monoclonal antibodies (mAbs) against CD4, CCR5, and CXCR4 in live HFAs or for receptor expression within intracellular vesicular compartments in which HIV-1 might fuse by fixing and permeabilizing HFAs ([Figure S1](#mmc1){ref-type="supplementary-material"}). Between 50% and 100% ([Figure S1](#mmc1){ref-type="supplementary-material"}D) of live and fixed-permeabilized CD4+ Jurkat T cells and MDMs, gated on isotype control antibody, expressed moderate to high levels of CD4 and CCR5 quantified by the geometric mean fluorescence intensity (GMFI) ([Figure S1](#mmc1){ref-type="supplementary-material"}E). By contrast, HFAs had no detectable signals above background under any condition. CXCR4 was expressed on Jurkat T cells, MDMs, and HFAs under all conditions, with a signal that increased after fixation and permeabilization, suggesting preferential reactivity of this antibody with fixed CXCR4 and/or CXCR4 expression both at the surface and in intracellular compartments.

Cell-free HIV-1 Does Not Fuse with Astrocytes {#sec2.2}
---------------------------------------------

Our data are consistent with infectious virion uptake into astrocytes without subsequent infection. To probe this in more detail, we carried out the well-characterized BlaM-Vpr assay, in which fusion of pseudoviruses (PVs) carrying a β-lactamase-Vpr fusion protein is reported by enzyme-catalyzed cleavage of the CCF2-AM substrate within the target cell cytoplasm, driving a green-to-blue change ([@bib8]). Reporter PVs expressing BaL or LAI HIV-1 *env* or VSV-G were concentrated and spinoculated onto HFA or MDM target cells to generate a robust input signal and were live-cell gated and assessed for viability before fixation and flow cytometric analysis ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C). [Figure 2](#fig2){ref-type="fig"}B shows that uninfected MDMs expressed no significant signal, whereas the VSV-G PV yielded ∼96% positive cells inhibited to ∼38% by chloroquine, an antagonist of endosomal acidification ([Figure 2](#fig2){ref-type="fig"}C). HIV-1~BaL~ PV gave ∼57% fusion with MDMs that was receptor-mediated, because the CD4 blocking mAb Q4120, the CCR5 antagonist TAK779 and the gp41 fusion inhibitor T20 reduced entry signals to background levels, whereas the CXCR4 antagonist AMD31000 failed to inhibit ([Figure 2](#fig2){ref-type="fig"}D). When HFAs were exposed to the same PV stocks, VSV-G PV transduced 99% of cells reduced to ∼49% by chloroquine, whereas HIV-1~BaL~ gave close to background signals that were not further reduced by receptor antagonists or T20 ([Figures 2](#fig2){ref-type="fig"}G and 2H). PV carrying the X4 *env* LAI failed to produce a significantly inhibitable signal in MDMs or HFAs, confirming a lack of entry into either cell type ([Figure 2](#fig2){ref-type="fig"}H; [Figure S2](#mmc1){ref-type="supplementary-material"}). Altogether, these results indicate that unlike VSV-G, HIV-1 Env is unable to mediate fusion with astrocytes. However, we did detect low-frequency (\<−2%) β-lactamase signals in HFAs that were not significantly reduced by entry inhibitors ([Figure 2](#fig2){ref-type="fig"}H). We hypothesized that this apparently non-specific substrate conversion arose from the spinoculation and/or fixation process associated with the reported HIV-1 binding activity of astrocytes ([@bib11], [@bib12], [@bib17], [@bib18], [@bib27], [@bib29], [@bib34]). To exclude this, we used a modified BlaM-Vpr assay that generates real-time data in live cells without spinoculation or fixation ([@bib45]). BlaM-Vpr HIV-1 without Env (HIVΔEnv) or pseudotyped with the R5 HIV-1~JRFL~ Env or VSV-G were incubated with CCF2-AM substrate-loaded cells at 4°C for 30 min before washing, warming to 37°C, and imaging ([Figure 3](#fig3){ref-type="fig"}A). The ratio of uncleaved to cleaved substrate was quantified pixel by pixel and plotted against time, using the signal derived from HIV-1ΔEnv virions at the final time point as a background control for no fusion. Individual MDMs showed a positive BlaM fusion signal from 20 min onward when exposed to HIV~JRFL~ and HIV-1~VSV-G~, with ∼30% and ∼16% red cells, respectively, by the final time point ([Figures 3](#fig3){ref-type="fig"}B--3D). By contrast, although HIV-1~VSV-G~ yielded ∼35% red cells at 140 min in HFAs, none were detectable at any time point with HIV-1~JRFL~ ([Figures 3](#fig3){ref-type="fig"}E--3G). Further evidence for an inability of HIV-1~JRFL~ to fuse with HFAs was obtained in real time using single-particle tracking. Gag-GFP HIV-1 virions double-labeled with the red fluorescent DiD membrane dye, resulting in yellow fluorescent particles, were incubated with cells for 30 min at 4°C, washed, and imaged every 8--12 s at 37°C for the times shown ([Figure 4](#fig4){ref-type="fig"}). Virion fusion leads to DiD diffusion into the limited endosomal membrane, turning it red, while the GFP-labeled capsid dissociates into the cytosol, leaving a red endosomal signal ([Figure 4](#fig4){ref-type="fig"}B) as previously described ([@bib40]). VSV-G fuses in an obligate pH-dependent manner from within endosomes, and HIV-1 Env fuses from within endosomes in MDMs, as previously demonstrated ([@bib7], [@bib56]). This is illustrated for HIV-1~VSV-G~ fusion with HFAs in [Figures 4](#fig4){ref-type="fig"}D and 4E and [Movie S1](#mmc2){ref-type="supplementary-material"}. A total of 28 fusion events (16%) for 250 HIV-1~VSV-G~ tracked particles were detected in HFAs over 6 min in ten independent experiments ([Figures 4](#fig4){ref-type="fig"}F and 4G). By contrast, not a single fusion event was detected when 250 HIV-1~JRFL~ particles were tracked over the same time frame in HFAs ([Figures 4](#fig4){ref-type="fig"}G--4J; [Movie S2](#mmc3){ref-type="supplementary-material"}). The slow loss of green fluorescence in [Figure 4](#fig4){ref-type="fig"}I represents a combination of particles moving out of focus and slow photobleaching of the green signal in the absence of fusion. However, both HIV-1~VSV-G~ and HIV-1~JRFL~ particles fused readily with MDMs ([Figure S3](#mmc1){ref-type="supplementary-material"}; [Movies S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}), confirming that this Env was fusion competent on permissive target cells. Altogether, these results confirm that HIV-1 particles cannot fuse with HFAs in live-cell systems over extended timescales during which VSV-G Env mediates multiple fusion events.

Transfer of HIV-1 from MDMs to HFAs by Cell-Cell Spread {#sec2.3}
-------------------------------------------------------

Previous studies have reported that cell-cell spread of HIV-1 to astrocytes may overcome blocks imposed on cell-free virus infection of these cells, resulting in a low-level infection of astrocytes within the culture ([@bib33], [@bib37], [@bib43]). Alternatively, astrocytes may endocytose virions released from infected cells without becoming infected but leading to the appearance of infection. To interrogate these possibilities, we established an infected MDM-HFA coculture system ([Figure 5](#fig5){ref-type="fig"}A). We could not use a BlaM-Vpr assay to probe cell-to-cell spread, because we were unable to produce sufficiently high titer BlaM-Vpr PV in MDMs. We therefore infected MDMs with the R5 reporter virus HIV-1~JRFL-iGFP~ for 7 days and cocultured them for 24 hr with HFAs. Cocultures were fixed and labeled for the astrocyte marker glial fibrillary acidic protein (GFAP) and imaged by confocal microscopy (CM). We observed a high percentage of HIV-1-infected MDMs associated with GFAP^+^ HFAs, and the two cell types were confirmed to be interacting intimately making multiple intercellular contacts by scanning electron microscopy ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). To probe the fate of individual HIV-1 particles transferred from MDMs to HFAs, we used super-resolution, stimulated emission depletion (STED) microscopy that has sufficient resolution to accurately image individual virions and viral Env ([@bib13]). HIV-1~BaL~-infected MDMs were cocultured with HFAs for 3 or 24 hr, fixed, permeabilized, and labeled for GFAP and Gag p24 ([Figures 5](#fig5){ref-type="fig"}A and 5B). Fields containing GFAP^+^ HFAs in close apposition to HIV-1~BaL~^+^ MDMs and in which virions were readily visible were selected for further analysis. At 3 hr post-coculture, virions were observed in proximity to, and associated with, HFA plasma membranes and frequently associated with astrocyte dendrites ([Figure 5](#fig5){ref-type="fig"}B) as previously described ([@bib22]). We quantified the association of virions with HFAs by acquiring *z* stacks of x-y images and counting individual virions within ∼2 μm of the astrocyte membrane as identified by GFAP label ([Figure 5](#fig5){ref-type="fig"}A). Virion-plasma membrane distances were only measured in the x-y plane, because the resolution in the z plane was insufficient to quantify accurately, as exemplified in [Figures 5](#fig5){ref-type="fig"}C and 5E. Data from 203 individual virions are summarized in [Figure 5](#fig5){ref-type="fig"}F, showing that all virions were either proximal to or associated with the HFA plasma membrane, but none were beneath the plasma membrane, demonstrating a lack of virion internalization by 3 hr. By contrast, when infected MDMs were cocultured with HFAs for 24 hr ([Figures 5](#fig5){ref-type="fig"}D and 5E), most virions (192 counted) were beneath the plasma membrane, implying efficient virus internalization ([Figure 5](#fig5){ref-type="fig"}F). Virion internalization might result from fusion with the HFA membrane or from endocytic uptake as previously described ([@bib11], [@bib12], [@bib17], [@bib18], [@bib27], [@bib29], [@bib34]). To differentiate between these possibilities, we double-labeled virions for Gag and Env and compared the percentage of double-positive virions beneath the HFA membrane with that of the same virus sample bound to the solid phase. If virion entry into HFAs was fusion mediated, then the Env signal would dissociate from Gag and remain associated with the cell membrane, whereas endocytosis would leave the two signals associated on virions. Comparison of virions within HFAs after 24 hr coculture with infected MDMs ([Figure 5](#fig5){ref-type="fig"}G) to cell-free virions released from the same MDM culture and coated onto on a glass surface ([Figure 5](#fig5){ref-type="fig"}H) revealed 69.6% and 69.1%, respectively, with colocalized Gag and Env, demonstrating no loss of Env upon virion internalization into HFAs. These data, together with our other lack of evidence of virus-HFA fusion, strongly support the hypothesis that virions released from infected, contacting MDMs are endocytosed into HFAs without subsequent fusion.

HFAs Interact Intimately with and Engulf HIV-1-Infected MDM Material {#sec2.4}
--------------------------------------------------------------------

HIV-1 proteins and nucleic acids, including integrated viral DNA, have been detected in astrocytes, yet we were unable to detect astrocyte infection in our systems. Although virions closely associated with HFA membranes would yield a signal positive for viral proteins and nucleic acids, this would not explain the detection of viral nucleic acids from nuclei within astrocytes as previously described ([@bib15]). Based on the phagocytic activity of astrocytes ([@bib9], [@bib35], [@bib36], [@bib39], [@bib52]), we hypothesized that this discrepancy might be explained by astrocyte phagocytosis of infected MDMs and their debris eliciting false-positive infectivity signals. To probe this, we used multispectral flow cytometry (ImageStream), which allows phenotypic and quantitative analysis of cell-cell interactions as previously described for MDM uptake of HIV-1-infected T cells ([@bib2]). MDMs infected for 7 days with HIV-1~BaL-iGFP~ were cocultured with DiD-labeled HFAs for 24 hr before lifting, fixation, permeabilization, labeling for CD14, and analysis ([Figure 6](#fig6){ref-type="fig"}A). Gating for single cells and multiple-cell conjugates was carried out as described ([Figure S5](#mmc1){ref-type="supplementary-material"}), and images were acquired. [Figures 6](#fig6){ref-type="fig"}B--6D show example images of an infected single MDM (CD14^+^/GFP^+^), uninfected HFAs (DiD^+^), and tight clusters of infected MDMs and HFAs. Quantification of these events ([Figure 6](#fig6){ref-type="fig"}G) revealed clustering of ∼14% ± 6% of HFAs and MDMs, of which 2.8 ± 2% were HIV-1^+^. Of particular significance, we observed combined "single" CD14^+^/DiD^+^/GFP^−^ events representing MDMs engulfed by HFAs (or potentially HFAs engulfed by MDMs) ([Figure 6](#fig6){ref-type="fig"}E) and CD14^+^/DiD^+^/GFP^+^ events representing infected MDMs engulfed by HFAs or possibly HFAs engulfed by infected MDMs ([Figure 6](#fig6){ref-type="fig"}F). Quantification of these single events revealed 10% ± 8% double positive for HFA and MDM markers and 1.6% ± 1.4% triple positive for HFAs, MDMs, and HIV-1. These images clearly reveal not only that MDMs and HFAs engage tightly into clusters but also that HFAs may engulf both uninfected MDMs, presumably damaged and dying cells, and infected MDMs, leading to apparent single cells triple positive for astrocyte, macrophage, and HIV-1 markers. Because the resolution of these images was insufficient to determine whether HFAs had engulfed MDM material, or vice versa, we carried out 3D confocal microscopy. HIV-1-infected MDMs were lifted and cocultured with HFAs for 24 hr and then fixed, permeabilized, and labeled for GFAP (HFAs) and HIV-1 Gag. Serial x-y optical sections were acquired in the z plane, and 3D reconstructions are shown in [Figures 6](#fig6){ref-type="fig"}H--6K and associated [Movies S5](#mmc6){ref-type="supplementary-material"} and [S6](#mmc7){ref-type="supplementary-material"}. [Figures 6](#fig6){ref-type="fig"}H--6K show two independent HFAs that had engulfed infected MDM material, the dimensions of which (multiple ∼1 μm infected MDM-derived vesicles in [Figures 6](#fig6){ref-type="fig"}H and 6I and a ∼5 μm infected MDM-derived fragment in [Figures 6](#fig6){ref-type="fig"}J and 6K) represent infected cellular material. Analysis of infected MDMs cocultured with HFAs for 24 hr (as imaged by CM and scanning EM in [Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B, respectively) by transmission electron microscopy (TEM) revealed an infected MDM partially engulfed by an HFA ([Figure S4](#mmc1){ref-type="supplementary-material"}C) and an apparently uninfected MDM potentially engulfed by an HFA ([Figure S4](#mmc1){ref-type="supplementary-material"}D). Altogether, these results confirm that astrocytes can closely interact with and engulf infected macrophages and macrophage-derived material that would give the appearance, in low-resolution images and by assay of viral nucleic acids and proteins, of infected astrocytes.

Discussion {#sec3}
==========

Our results demonstrate unequivocally that cell-free HIV-1 is unable to fuse with and infect HFAs, in line with the absence of CD4 and CCR5 expression. However, astrocytes adsorb and internalize HIV-1 virions and engulf fragments of HIV-1-infected macrophages via "eat me" signals that are likely to derive from cell stress, damage, and death ([@bib9], [@bib35], [@bib36], [@bib39], [@bib52]), although we cannot exclude additional infection-specific recognition signals. We therefore propose that previous reports of HFA infection in many in vitro and ex vivo analyses may be explained as follows. First, astrocyte adsorption and uptake of cell-free virus particles would lead to detection of infectious virions, viral proteins, and nucleic acids in cultured or ex vivo analyzed astrocytes ([@bib1], [@bib16], [@bib54], [@bib55]). Second, astrocyte binding to, and engulfment of, HIV-1-infected permissive cells and subcellular material either in coculture (as we have seen for infected MDMs) or in vivo would likewise lead to detection of astrocyte-associated viral proteins and nucleic acids that could be mistaken for infection. Astrocyte engulfment of entire infected cells could lead to detection of integrated viral DNA within permissive cell nuclei inside astrocytes, as described ex vivo in HIV-1-infected brain tissue ([@bib15]) and be interpreted as astrocyte infection. Of particular relevance to this concept, [@bib16] reported that detection of HIV-1 DNA in astrocytes correlated with proximity to perivascular macrophages, which are productively infected in vivo ([@bib4], [@bib53]). Also relevant to this hypothesis, myeloid cells isolated from HIV-1-infected patients ([@bib32]) and simian immunodeficiency virus (SIV)-infected macaques ([@bib5]) were positive both for HIV-1 DNA and for rearranged T cell receptor sequences, implying myeloid cell phagocytosis of HIV-1-infected T cells. By contrast with astrocytes, however, macrophages express CD4 and CCR5 and are therefore permissive for HIV-1 infection following infected T cell engulfment ([@bib2], [@bib49]).

Our data are consistent with a model proposed by others in which virions adhere to, and are taken up by, HFAs into a compartment from which small amounts of infectious virus may subsequently be released ([@bib11], [@bib12], [@bib17], [@bib18], [@bib27], [@bib29], [@bib34]). Astrocytes with engulfed infected material from permissive cells may also transiently release virus, although we have not directly demonstrated this in the current study. However, in neither case would astrocytes be likely to form a long-lived viral reservoir, because virus release from such archives would depend entirely upon the production of new virus in the CNS by permissive cells such as microglia and perivascular macrophages.

We, like many others ([@bib10], [@bib22], [@bib26], [@bib28], [@bib43]), have used HFAs as a source of target cells in this study. Although primary cells, they are fetal and therefore are likely to differ phenotypically from adult astrocytes. Another potential source of adult astrocytes is post-operative neural tissue. However, these astrocyte preparations are not homogeneous, and even very small proportions of contaminating CD4^+^ T cells or macrophage-lineage cells would confound interpretation of infectivity analyses. Appropriately differentiated stem cells might provide alternative sources of astrocytes, but at present differentiation results in heterogeneous cell populations whose biological relevance to tissue-derived astrocytes remains to be fully defined ([@bib30]). We cannot exclude the possibility that astrocytes in situ exposed to the neural tissue environment may be induced to express CD4 and CCR5 and therefore, along with endogenous CXCR4 expression, be susceptible to HIV-1 infection in vivo. Our study nevertheless provides compelling evidence that primary human astrocytes are not infectible in vitro and suggests testable hypotheses regarding the nature of HIV-1 nucleic acid and protein signatures associated with these cells. Future studies should therefore focus on high-resolution imaging analyses of astrocytes in neural tissue to determine whether HIV-1 signals originate from engulfment of infected material rather than true infection.

Experimental Procedures {#sec4}
=======================

Cells and Tissue Culture {#sec4.1}
------------------------

Human fetal astrocytes (HFAs) (ScienCell Research Laboratories), isolated from second trimester fetal cerebral cortex, were cultured in astrocyte media (ScienCell Research Laboratories) with 1% penicillin and streptomycin (P/S), 2% fetal bovine serum (FBS), and 1% astrocyte growth supplement (optimized insulin, transferrin, fibroblast growth factor, insulin-like growth factor 1, hydrocortisone, and progesterone). Blood-derived monocytes were isolated from peripheral blood mononuclear cells using Human Monocyte Isolation Kit II (Miltenyi Biotec) according to manufacturer's instructions. Monocytes were cultured in X-vivo (Lonza) with 1% heterologous human serum (Sigma) for 7 to 10 days, during which time they differentiated into monocyte-derived macrophages (MDMs). TZM-bl cells (NIH AIDS Research and Reference Reagent Program) and 293T cells were grown in DMEM (Sigma) with 1% P/S and 10% FBS.

Viruses {#sec4.2}
-------

Viruses were prepared by transient transfection of 293T cells and titrated on TZM-bl cells. Also see [Supplemental Information](#app3){ref-type="sec"}.

Cell-free Infection {#sec4.3}
-------------------

HFAs (1 × 10^4^), MDMs (1 × 10^5^), and TZM-bl cells (1 × 10^4^) were seeded in 96-well plates and infected for 24 hr with HIV-1~BaL-LucR~, HIV-1~YU2-LucR~, or HIV-1~NL4.3-LucR~ at a MOI of 0.1, determined by titration on TZM-bl cells. In AZT-containing samples, 10 μM AZT were added to the cells 1 hr before infection. At 24 hr post-infection, virus was washed off and cells were incubated in ±10 μM AZT for a further 24 hr and then at 48 hr intervals until 10 days post-infection. For harvesting, cells were incubated in 60 μL GloLysis buffer (Promega) for 2 min before freezing at −80°C. Lysates were thawed and 50 μL were combined with 50 μL Renilla-Glo Luciferase reagent (Promega). Plates were analyzed in a SpectraMax M5 (Molecular Devices) using SpectraMax Pro v.5 with an integration of 1,000 ms. Supernatant p24 was assayed using an in-house p24 ELISA as previously described ([@bib2]). Briefly, inactivated and detergent (Empigen)-treated cell-free supernatants were incubated in ELISA plate wells pre-coated with anti-p24 antibody (D7320, Aalto), followed by detection with biotinylated anti-p24 antibody (BC1071-BIOT, Aalto). The signal was developed using TMB Turbo One-Step Substrate (Pierce) and stopped with 0.5 M H~2~SO~4~, and optical density 450 (OD~450~) was determined.

BlaM-Vpr Fusion Assay {#sec4.4}
---------------------

Fusion was assayed using the GeneBLAzer kit (Life Technologies) as described ([@bib8]). Drug concentrations were 500 nM Tak779 (CFAR), 1 μM AMD3100 (CFAR), 7.5 μg/mL T20 (NIH AIDS Reagents), 10 μg/mL Q4120, and 50 μg/mL chloroquine (Sigma).

Live-Cell Real-Time BlaM-Vpr Assay {#sec4.5}
----------------------------------

Cells were plated at 3 × 10^5^ (MDMs) or 1 × 10^5^ (HFAs) cells/well in 8-well μ-Slides (Ibidi). On the day of assay, cells were loaded with CCF2-AM from the LiveBLAzer FRET-B/G Loading Kit (Life Technologies) and incubated at room temperature (RT) in the dark for 2 hr with 12.5 mM probenecid. CCF2-AM was removed, and cells were washed with PBS and cooled on ice before the addition of PV harboring BlaM-Vpr (HIV~No\ Env~, HIV~VSV-G~, and HIV~JR-FL~), MOI = 3 in 100 μL. Cells were incubated at 4°C for 30 min with 12.5 mM probenecid. Cells were washed with PBS to remove unbound particles, fresh medium containing 12.5 mM probenecid was added, and cells were imaged on a Leica SP8XSMD confocal microscope at 37°C. Observations were recorded from 300--500 cells/field, with three fields/experiment. Also see [Supplemental Information](#app3){ref-type="sec"}.

Live-Cell Single-Virus Tracking {#sec4.6}
-------------------------------

Single-virus tracking in live MDMs and HFAs was performed as in [@bib31] and is described in more detail in [Supplemental Information](#app3){ref-type="sec"}.

ImageStream {#sec4.7}
-----------

MDMs infected with HIV-1~BaL-iGFP~ were lifted with 12 mM lidocaine/5 mM EDTA in PBS and added to DiD (Molecular Probes)-labeled HFAs seeded at 5 × 10^6^ cells/dish. Cells were cocultured for 24 hr before lifting and fixation for 15 min in 4% formaldehyde in PBS. Cells were permeabilized in 0.1% saponin (Sigma) and 30% FCS for 30 min at RT before labeling for CD14 (CD14-eFluor450, eBioscience). Cells were analyzed on an ImageStream X Mark II (Amnis) with a 20× or 40× objective with extended depth of field (EDF) and data processed using Ideas v.6 (Amnis).

Confocal and STED Microscopy {#sec4.8}
----------------------------

Adherent cells (MDMs and HFAs) were washed and fixed in 4% paraformaldehyde (PFA) for 15 min, followed by washing in PBS and storage in 1% BSA/PBS. For confocal and stimulated emission depletion (STED) microscopy, 37G12 (anti-p24) and 2G12 (anti-gp120) antibodies (Polymun) were coupled to ATTO 490LS (Atto-Tec) or Abberior STAR 635P (Abberior) dyes via n-hydroxysuccinimide (NHS)-ester chemistry following manufacturer's instructions. GFAP was visualized using rabbit anti-GFAP Ab (Abcam) and anti-rabbit ATTO 490LS (Atto-Tec) or Alexa 488 (Life Technologies). Also see [Supplemental Information](#app3){ref-type="sec"}.
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![HFAs Are Not Productively Infected by HIV-1 but Trap and Release Viral Gag\
(A--H) TZM-bl cells (A, B), MDMs (C, D), and HFAs (E--H) were incubated overnight with or without AZT with HIV-1 luciferase reporter viruses at MOI = 0.1, washed, and cultured with or without AZT. At the times shown, cells were lysed and assayed for luciferase activity (A, C, E, and G) or supernatants were harvested and assayed for Gag p24 by ELISA (B, D, F, and H). (G) and (H) represent (E) and (F), respectively, with expanded scales. The dotted line in (G) shows the background luciferase signal obtained with uninfected HFAs. Data represent means of three to five independent experiments ± SD using five MDM donors.](gr1){#fig1}

![No Detection of HIV-1 Env Fusion with HFAs by BlaM-Vpr Assay\
(A) Experimental plan.\
(B--D) MDMs were untreated or treated with inhibitors and then mock-transduced (B) or transduced with VSV-G (C) or HIV-1 BaL Env-pseudotyped BlaM-Vpr HIV-1 (D) for 16 hr. Cells were then lifted, fixed, and analyzed by flow cytometry.\
(E--G) HFAs were untreated or treated with inhibitors and then mock-transduced (E) or transduced with VSV-G (F) or HIV-1 BaL-pseudotyped BlaM-Vpr HIV-1 (G) for 16 hr. Cells were then lifted, fixed, and analyzed by flow cytometry.\
(H) Means of data from three to five independent experiments ± SD using five MDM donors, including summarized results for LAI, presented in [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Live-Cell Fusion Assay Does Not Detect HIV-1 Env Fusion with HFAs\
(A) Experimental plan.\
(B and C) CCF2-loaded MDMs exposed to HIV-1 BlaM-Vpr pseudotyped with HIV-1 JRFL (B) or VSV-G Env (C) were imaged at the times shown.\
(D) Quantified results from (B) and (C) showing the percentage of red cells as a function of time with the sigmoidal curve fit. Mean of three independent experiments ± SD using three MDM donors.\
(E and F) CCF2-loaded HFAs exposed to HIV-1 BlaM-Vpr pseudotyped with HIV-1 JRFL (E) or VSV-G Env (F) were imaged at the times shown.\
(G) Quantified results from (E) and (F), showing the percentage of red cells as a function of time with the sigmoidal curve fit. Mean of three independent experiments ± SD.\
Blue pseudocolor represents no fusion; red represents fusion. Scale bar, 70 μm.](gr3){#fig3}

![Single-Particle Tracking Fails to Reveal HIV-1 Env Fusion with HFAs\
(A) Experimental plan.\
(B) Cartoon of entry assay events. Yellow double-labeled (DiD, red; GFP, green) virions enter the cell by endocytosis. Fusion results in the red label entering the endosomal membrane and the green signal moving into the cytosol away from the plane of focus, leaving a red vesicular signal.\
(C) Low-magnification x-y CM image of single- and double-labeled HIV-1-VSV-G particles on HFAs at T = 0. Arrowhead points to the double-labeled virion that fuses in (D). Scale bar, 10 μm.\
(D) Close-up of white boxed area in (B) at T = 0 (left panel) and T = 5 min (right panel). Arrowheads point to the virion (yellow in the left panel) and the fusion event (red in the right panel). Region of interest represents 10 × 10 μm. See [Movie S1](#mmc2){ref-type="supplementary-material"}.\
(E) Data from the fusion event tracked in (C), in which the signal for the green channel is lost between 3.5 and 5 min while the red channel signal remains constant.\
(F) Kinetic distribution of 28 single fusion events from four independent experiments.\
(G) Low-magnification image of single- and double-labeled HIV-1-JRFL particles on HFAs at T = 0. Scale bar, 10 μm.\
(H) Close-up of white boxed area in (G) at T = 0 (left panel) and T = 21 min (right panel). Arrowheads indicate double-labeled yellow virions. Region of interest is 15 × 12 μm. See [Movie S2](#mmc3){ref-type="supplementary-material"}.\
(I) Data quantified from a virion tracked in (H) in which the signal for red and green channels remains constant after initial photobleaching of the green signal between 0 and 10 min.\
(J) Summary of fusion events totaling ∼17% of all tracked yellow double-labeled particles (36 of 250) for VSV-G and 0% (0 of 250) for JR-FL. Data presented are from ten independent experiments using three MDM donors. See [Figure S3](#mmc1){ref-type="supplementary-material"} and [Movies S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"} for fusion data in MDMs.](gr4){#fig4}

![STED Analysis of HIV-1 Transfer from MDMs to HFAs\
(A) Experimental chart and approach for measurement of virion-membrane distances.\
(B) Coculture of HIV-1~BaL~-infected MDMs with HFAs (GFAP, green) for 3 hr, with virions released from the MDMs labeled in red. Inset shows a low-magnification image, with MDMs outlined in blue. Scale bar, 500 nm; inset scale bar, 3 μm.\
(C) 3D z projection of x-y sections through HFAs showing loss of resolution in the z plane.\
(D) Coculture of HIV-1~BaL~-infected MDMs with HFAs (GFAP, green) for 24 hr, with virions released from the MDMs in orange. Inset shows a low-magnification image, with MDMs outlined in blue. Scale bar, 500 nm; inset scale bar, 3 μm.\
(E) 3D z projection of x-y sections through HFAs showing loss of resolution in the z plane.\
(F) Distance of individual HIV-1 particles from HFA plasma membrane at 3 and 24 hr post-MDM-HFA coculture. Dotted line represents membrane, black line is mean, and p \< 0.0001, determined by Student's t test. Data are from two independent experiments using two MDM donors.\
(G) 3D z projection of Env/Gag-labeled HIV-1 particles associated with an HFA after 24 hr coculture with infected MDMs, of which \>50% are internalized into HFAs. Scale bar, 500 nm; inset scale bar, 200 nm.\
(H) Representative images of Gag/Env-labeled HIV-1 particles adhered to a coverslip. Scale bar, 200 nm.](gr5){#fig5}

![HFAs Interact with and Engulf HIV-1-Infected MDM Material\
(A) Experimental plan.\
(B) Single infected MDMs (two independent examples) showing bright-field (BF) morphology and DiD^−^/GFP^+^/CD14^+^ phenotype.\
(C) Single HFAs (two independent examples) showing BF morphology and DiD^+^/GFP^−^/CD14^−^ phenotype.\
(D) Clustered cells (two independent examples) showing BF morphology of conjugates of infected MDMs (DiD^−^/GFP^+^/CD14^+^) and HFAs (DiD^+^/GFP^−^/CD14^−^).\
(E) Combined single events (two independent examples) of uninfected MDMs (DiD^−^/GFP^−^/CD14^+^) and HFAs (DiD^+^/GFP^−^/CD14^−^).\
(F) Combined infected MDM (DiD^−^/GFP^+^/CD14^+^) and HFA (DiD^+^/GFP^−^/CD14^−^) single events (two independent examples).\
(G) Quantification of clustered cells and single events showing individual datum points and means from data collected in five independent experiments, each with 5,000--10,000 events analyzed with four MDM donors ± SD. See [Figure S5](#mmc1){ref-type="supplementary-material"} for the ImageStream gating strategy.\
(H) HIV-1-infected MDMs and HFAs were cocultured for 24 hr, immunostained for GFAP (green) and p24 (red), and imaged by CM. The z projection of optical slices corresponds to the astrocyte body; the red box indicates dimensions. See [Movie S5](#mmc6){ref-type="supplementary-material"}.\
(I) Single x-y optical section though the white boxed region of the HFAs in (H). Scale bar, 2 μm.\
(J) HIV-1-infected MDMs and HFAs were cocultured, labeled, and imaged as for (H). The red box indicates dimensions. See [Movie S6](#mmc7){ref-type="supplementary-material"}.\
(K) Single x-y optical section though the white boxed region of the HFAs in (J). Scale bar, 2 μm. See also [Figure S4](#mmc1){ref-type="supplementary-material"} for TEM images of MDMs interacting with and engulfed by HFAs.](gr6){#fig6}
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